SZShuqiong Zheng

Shuqiong Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuqiong Zheng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Validity, reliability, and responsiveness of the work productivity and activity impairment in patients with insomnia disorder

    by Aike Wu, Hangyi Yang, Shixu Du, Shuqiong Zheng, Zhiting Huang, Leqin Fang, Bin Zhang

    Objectives: This study aimed to evaluate the validity, reliability, and responsiveness of the work productivity and activity impairment (WPAI) in patients with insomnia disorder. Methods: A total of 1075 patients with insomnia disorder were recruited. Convergent validity was assessed by correlations between the WPAI outcomes (absenteeism, presenteeism, overall work productivity loss, and activity impairment) and Insomnia Severity Index (ISI), Patient Health Questionnaire‐9 (PHQ‐9), Generalized Anxiety Disorder‐7 (GAD‐7), and quality‐adjusted life years (QALYs). Known‐group validity was tested by comparing the WPAI outcomes between groups with differing symptom severity. Responsiveness was evaluated by comparing WPAI score changes between responders and nonresponders based on the minimum clinically important difference of ISI. Test–retest reliability was calculated using intraclass correlation coefficient (ICC) in clinically stable patients over 3 months. Results: All WPAI domains were significantly correlated with ISI, PHQ‐9, GAD‐7, and QALYs scores ( r = 0.20–0.46, all p < 0.001). Patients with greater symptom severity had significantly higher WPAI scores (all p < 0.001). Clinical responders showed statistically greater decreases in presenteeism, overall work productivity loss, and activity impairment (all p < 0.001). WPAI represented moderate stability (ICC = 0.56–0.69) over 3 months except for absenteeism (ICC = 0.41). Conclusions: The WPAI is a valuable instrument for assessing work productivity and activity impairment in patients with insomnia disorder.

  • Open Access

    Differential Anxiety–Depression–CRP Network Structures Across Insomnia Severity Levels: Evidence From UK Biobank

    by Xue Luo, Shuqiong Zheng, Yihong Cheng, Shuai Liu, Shufei Zeng, Leqin Fang, Shixu Du, Weimin Li, Hangyi Yang, Zhiting Huang, et al.

    Background: This study investigated the relationships between anxiety, depression symptoms, and C‐reactive protein (CRP) across insomnia severity levels using network analysis and examined the structural differences within these networks. Methods: Gaussian graphical model network analysis with Least Absolute Shrinkage and Selection Operator (LASSO) regularization was conducted on UK Biobank data ( N = 143,027). Depression and anxiety symptoms were assessed using the 9‐item Patient Health Questionnaire (PHQ‐9) and 7‐item Generalized Anxiety Disorder Scale (GAD‐7), respectively. CRP was quantified using immunoturbidimetric‐high‐sensitivity analysis. Participants were categorized by insomnia frequency (never/rarely, sometimes, and usually). The strength symptoms and expected influence identified core symptoms, while bridge expected influence (bridge EI) determined bridge symptoms. Network comparison tests (NCTs) were performed pairwise across the three groups to assess differences in global strength and edge weights. Results: Across all networks, “Depressed mood” demonstrated the highest strength centrality, while “Irritability” exhibited the highest bridge EI. “Depressed mood” had the highest expected influence centrality in the never/rarely insomnia group and “Uncontrollable worry” in other groups. NCTs revealed significant differences in global strength ( S = 0.178, p < 0.01) and edge weights ( M = 0.062, p < 0.01) between the never/rarely and usually insomnia groups, with stronger connections between depressive symptoms (energy/appetite) and CRP in the usually insomnia group ( p < 0.001). Conclusions: The central roles of depressed mood, uncontrollable worry, and irritability in the anxiety–depression–CRP network across all insomnia severity groups suggest that these symptoms represent potential targets for future intervention research. Notably, network structure differed across insomnia severity; the strengthened associations between depressive symptoms and CRP in the usually insomnia group suggest that insomnia severity may be an important factor to consider in understanding the relationships between affective and inflammatory processes.


  • Open Access

    Machine Learning Models to Identify Clinically Significant Anxiety in Short‐Term Insomnia Using Accelerometers

    by Leqin Fang, Weixiong Zeng, Shuqiong Zheng, Shixu Du, Hangyi Yang, Xue Luo, Shufei Zeng, Zhiting Huang, Weiguo Chen, Bin Zhang

    Clinically significant anxiety (CSA) is common in individuals with short‐term insomnia. This study aims to explore the relationship between CSA and the subjective and objective parameters of sleep in patients with short‐term insomnia and construct machine learning (ML) models to determine the utility of accelerometer features in identifying significant anxiety. A total of 205 short‐term insomnia participants from China were assigned to the group with CSA ( N = 33) or the group without CSA ( N = 172). Interaction analysis based on linear regression was used to estimate the possible interactive effect of accelerometer features between CSA and sleep problems. Four feature sets and eight algorithms were used to construct ML models, with Shapley Additive exPlanations (SHAP) values used to visualize feature importance and influence processes. CSA in patients with short‐term insomnia leads to more severe subjective sleep problems, and accelerometer‐measured features warrant further attention for the identification of interactive factors. A significant interaction effect was found between anxiety symptoms and longer duration of physical activity on insomnia severity ( P interaction < 0.05). Anxiety symptoms and interdaily stability had an interactive association with sleep hygiene behaviors ( P interaction < 0.01). ML can process and analyze complex accelerometer features to identify CSA in patients with short‐term insomnia. Compared with other feature sets and algorithms, the XGBoost model with accelerometer‐measured features on weekdays more effectively identified CSA with area under the curve (AUC) value of 0.777. SHAP analysis results indicated that circadian rhythm features had significant contributions. Decision plots based on SHAP were applied to visualize the personalized risk factors for each patient and provide clinicians with more easily understandable and practical explanation methods that enhance clinical decision‐making. Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR2200062910


  • Open Access

    A Naturalistic Prospective Study of the Prognostic Impact of EPHX2 in Major Depressive Disorder: Impulsivity may be an Important Factor

    by Shuqiong Zheng, Jia Guo, Rongxin Zheng, Yujia Ji, Quan Zhong, Honglei Yin

    Background: Major depressive disorder (MDD) is a leading cause of disability worldwide. The pathophysiology of MDD remains unclear, which limits the development of treatments for MDD. Recently, epoxide hydrolase 2 (EPHX2) has been found to be associated with MDD. Our previous study revealed an association between EPHX2 expression and suicide. However, the effect of EPHX2 on the prognosis of MDD and suicide remains unclear. Previous studies have found that impulsivity at baseline can be a significant predictor of clinical improvement in patients with MDD. Therefore, we inferred that EPHX2 could be associated with the treatment effect of MDD, and impulsivity could mediate the effect of EPHX2 on the treatment effect of MDD. Methods: This naturalistic prospective study included 117 participants with MDD, who were assessed, using clinical questionnaires, cognitive function, and treatment information, at baseline, 2 weeks, and 1, 2, and 3 months. A linear mixed‐effects model was used to investigate longitudinal changes in the severity of symptoms, risk of suicide, and cognitive function. Results: The interactive effects of impulsivity and EPHX2 polymorphisms on the risk of suicide (measured by the Columbia‐Suicide Severity Rating Scale) were significantly different for rs11288636, rs68012435, and rs11288636. The interactive effects between polymorphisms and time on depression severity (measured by the Hamilton Depression Scale‐24) were significantly different and including after adjustment for the total impulsivity score. Conclusions: This study suggests that EPHX2 polymorphisms are associated with the prognosis of MDD, and impulsivity could be a critical factor for the change in suicide risk among different EPHX2 genotypes. Trial Registration: ClinicalTrials.gov identifier: NCT05575713

  • Open Access

    Predictive Models for Suicide Attempts in Major Depressive Disorder and the Contribution of EPHX2: A Pilot Integrative Machine Learning Study

    by Shuqiong Zheng, Weixiong Zeng, Qianyun Wu, Weimin Li, Zilong He, Enze Li, Chong Tang, Xiang Xue, Genggeng Qin, Bin Zhang, et al.

    Suicide is a major public health problem caused by a complex interaction of various factors. Major depressive disorder (MDD) is the most prevalent psychiatric disorder associated with suicide; therefore, it is essential to prioritize suicide prediction and prevention within this population. Integrated information from different dimensions, including personality, cognitive function, and social and genetic factors, is necessary to improve the performance of predictive models. Besides, recent studies have indicated the critical roles for EPHX2/P2X2 in the pathophysiology of MDD. Our previous studies found an association of EPHX2 and P2X2 with suicide in MDD. This study is aimed at (1) establishing predictive models with integrated information to distinguish MDD from healthy volunteers, (2) estimating the suicide risk of MDD, and (3) determining the contribution of EPHX2/P2X2. This cross-sectional study was conducted on 472 prospectively collected participants. The machine learning (ML) technique using Extreme Gradient Boosting (XGBoost) classifier was employed to evaluate the performance and relative importance of the extracted characteristics in recognising patients with MDD and depressed suicide attempters (DSA). In independent validation set, the model with clinical and cognitive information could recognise MDD with an area under the receiver operating characteristic curve (AUC) of 0.938 (95% confidence interval (CI), 0.898–0.977), and genetic information did not improve classification performance. The model with clinical, cognitive, and genetic information resulted in a significantly higher AUC of 0.801 (95% CI, 0.719–0.884) for identifying DSA than the model with only clinical information, in which the three single nucleotide polymorphisms of EPHX2 showed important roles. This study successfully established step-by-step predictive ML models to estimate the risk of suicide attempts in MDD. We found that EPHX2 can help improve the performance of suicidal predictive models. This trial is registered with NCT05575713.